nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—Alkylating Activity—Ifosfamide—testicular cancer	0.378	0.529	CiPCiCtD
Procarbazine—Alkylating Activity—Chlorambucil—testicular cancer	0.337	0.471	CiPCiCtD
Procarbazine—XDH—Carboplatin—testicular cancer	0.0773	0.356	CbGbCtD
Procarbazine—XDH—Cisplatin—testicular cancer	0.0661	0.304	CbGbCtD
Procarbazine—XDH—Doxorubicin—testicular cancer	0.0443	0.204	CbGbCtD
Procarbazine—CYP1B1—Doxorubicin—testicular cancer	0.0294	0.136	CbGbCtD
Procarbazine—Eosinophilia—Methotrexate—testicular cancer	5.91e-05	0.000859	CcSEcCtD
Procarbazine—Nausea—Vinblastine—testicular cancer	5.91e-05	0.000858	CcSEcCtD
Procarbazine—Anorexia—Cisplatin—testicular cancer	5.9e-05	0.000857	CcSEcCtD
Procarbazine—Gastrointestinal pain—Ifosfamide—testicular cancer	5.87e-05	0.000853	CcSEcCtD
Procarbazine—Pancreatitis—Methotrexate—testicular cancer	5.86e-05	0.000851	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Epirubicin—testicular cancer	5.82e-05	0.000846	CcSEcCtD
Procarbazine—Hypotension—Cisplatin—testicular cancer	5.78e-05	0.00084	CcSEcCtD
Procarbazine—Hypersensitivity—Dactinomycin—testicular cancer	5.77e-05	0.000838	CcSEcCtD
Procarbazine—Confusional state—Etoposide—testicular cancer	5.72e-05	0.00083	CcSEcCtD
Procarbazine—Urticaria—Ifosfamide—testicular cancer	5.7e-05	0.000828	CcSEcCtD
Procarbazine—Abdominal pain—Ifosfamide—testicular cancer	5.68e-05	0.000824	CcSEcCtD
Procarbazine—Body temperature increased—Ifosfamide—testicular cancer	5.68e-05	0.000824	CcSEcCtD
Procarbazine—Pancytopenia—Methotrexate—testicular cancer	5.67e-05	0.000824	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Cisplatin—testicular cancer	5.64e-05	0.000819	CcSEcCtD
Procarbazine—Infection—Etoposide—testicular cancer	5.63e-05	0.000818	CcSEcCtD
Procarbazine—Ataxia—Doxorubicin—testicular cancer	5.63e-05	0.000817	CcSEcCtD
Procarbazine—Asthenia—Dactinomycin—testicular cancer	5.62e-05	0.000816	CcSEcCtD
Procarbazine—Dysphagia—Epirubicin—testicular cancer	5.59e-05	0.000812	CcSEcCtD
Procarbazine—Paraesthesia—Cisplatin—testicular cancer	5.56e-05	0.000807	CcSEcCtD
Procarbazine—Thrombocytopenia—Etoposide—testicular cancer	5.55e-05	0.000806	CcSEcCtD
Procarbazine—Tachycardia—Etoposide—testicular cancer	5.53e-05	0.000804	CcSEcCtD
Procarbazine—Eosinophilia—Epirubicin—testicular cancer	5.53e-05	0.000804	CcSEcCtD
Procarbazine—Hyperhidrosis—Etoposide—testicular cancer	5.48e-05	0.000796	CcSEcCtD
Procarbazine—Pancreatitis—Epirubicin—testicular cancer	5.48e-05	0.000796	CcSEcCtD
Procarbazine—Photosensitivity reaction—Methotrexate—testicular cancer	5.45e-05	0.000792	CcSEcCtD
Procarbazine—Angina pectoris—Epirubicin—testicular cancer	5.45e-05	0.000791	CcSEcCtD
Procarbazine—Anorexia—Etoposide—testicular cancer	5.41e-05	0.000785	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	5.39e-05	0.000783	CcSEcCtD
Procarbazine—Decreased appetite—Cisplatin—testicular cancer	5.38e-05	0.000782	CcSEcCtD
Procarbazine—Diarrhoea—Dactinomycin—testicular cancer	5.36e-05	0.000779	CcSEcCtD
Procarbazine—Pneumonia—Methotrexate—testicular cancer	5.36e-05	0.000778	CcSEcCtD
Procarbazine—Vomiting—Bleomycin—testicular cancer	5.34e-05	0.000776	CcSEcCtD
Procarbazine—Drowsiness—Methotrexate—testicular cancer	5.33e-05	0.000774	CcSEcCtD
Procarbazine—Pancytopenia—Epirubicin—testicular cancer	5.31e-05	0.000771	CcSEcCtD
Procarbazine—Hypotension—Etoposide—testicular cancer	5.3e-05	0.00077	CcSEcCtD
Procarbazine—Rash—Bleomycin—testicular cancer	5.3e-05	0.000769	CcSEcCtD
Procarbazine—Pain—Cisplatin—testicular cancer	5.29e-05	0.000769	CcSEcCtD
Procarbazine—Dermatitis—Bleomycin—testicular cancer	5.29e-05	0.000769	CcSEcCtD
Procarbazine—Hypersensitivity—Ifosfamide—testicular cancer	5.29e-05	0.000768	CcSEcCtD
Procarbazine—Stomatitis—Methotrexate—testicular cancer	5.19e-05	0.000754	CcSEcCtD
Procarbazine—Dysphagia—Doxorubicin—testicular cancer	5.17e-05	0.000751	CcSEcCtD
Procarbazine—Pollakiuria—Epirubicin—testicular cancer	5.16e-05	0.00075	CcSEcCtD
Procarbazine—Asthenia—Ifosfamide—testicular cancer	5.15e-05	0.000748	CcSEcCtD
Procarbazine—Eosinophilia—Doxorubicin—testicular cancer	5.12e-05	0.000744	CcSEcCtD
Procarbazine—Sweating—Methotrexate—testicular cancer	5.11e-05	0.000742	CcSEcCtD
Procarbazine—Photosensitivity reaction—Epirubicin—testicular cancer	5.1e-05	0.000741	CcSEcCtD
Procarbazine—Feeling abnormal—Cisplatin—testicular cancer	5.1e-05	0.000741	CcSEcCtD
Procarbazine—Paraesthesia—Etoposide—testicular cancer	5.09e-05	0.00074	CcSEcCtD
Procarbazine—Pruritus—Ifosfamide—testicular cancer	5.08e-05	0.000738	CcSEcCtD
Procarbazine—Haematuria—Methotrexate—testicular cancer	5.08e-05	0.000738	CcSEcCtD
Procarbazine—Pancreatitis—Doxorubicin—testicular cancer	5.07e-05	0.000737	CcSEcCtD
Procarbazine—Somnolence—Etoposide—testicular cancer	5.04e-05	0.000732	CcSEcCtD
Procarbazine—Angina pectoris—Doxorubicin—testicular cancer	5.04e-05	0.000732	CcSEcCtD
Procarbazine—Epistaxis—Methotrexate—testicular cancer	5.02e-05	0.00073	CcSEcCtD
Procarbazine—Pneumonia—Epirubicin—testicular cancer	5.01e-05	0.000728	CcSEcCtD
Procarbazine—Nausea—Bleomycin—testicular cancer	4.99e-05	0.000725	CcSEcCtD
Procarbazine—Drowsiness—Epirubicin—testicular cancer	4.98e-05	0.000724	CcSEcCtD
Procarbazine—Vomiting—Dactinomycin—testicular cancer	4.98e-05	0.000724	CcSEcCtD
Procarbazine—Rash—Dactinomycin—testicular cancer	4.94e-05	0.000718	CcSEcCtD
Procarbazine—Decreased appetite—Etoposide—testicular cancer	4.93e-05	0.000716	CcSEcCtD
Procarbazine—Diarrhoea—Ifosfamide—testicular cancer	4.91e-05	0.000714	CcSEcCtD
Procarbazine—Pancytopenia—Doxorubicin—testicular cancer	4.91e-05	0.000713	CcSEcCtD
Procarbazine—Body temperature increased—Cisplatin—testicular cancer	4.89e-05	0.000711	CcSEcCtD
Procarbazine—Fatigue—Etoposide—testicular cancer	4.89e-05	0.00071	CcSEcCtD
Procarbazine—Neuropathy peripheral—Epirubicin—testicular cancer	4.89e-05	0.00071	CcSEcCtD
Procarbazine—Stomatitis—Epirubicin—testicular cancer	4.86e-05	0.000706	CcSEcCtD
Procarbazine—Jaundice—Epirubicin—testicular cancer	4.86e-05	0.000706	CcSEcCtD
Procarbazine—Pain—Etoposide—testicular cancer	4.85e-05	0.000704	CcSEcCtD
Procarbazine—Constipation—Etoposide—testicular cancer	4.85e-05	0.000704	CcSEcCtD
Procarbazine—Haemoglobin—Methotrexate—testicular cancer	4.81e-05	0.000698	CcSEcCtD
Procarbazine—Haemorrhage—Methotrexate—testicular cancer	4.78e-05	0.000694	CcSEcCtD
Procarbazine—Sweating—Epirubicin—testicular cancer	4.78e-05	0.000694	CcSEcCtD
Procarbazine—Pollakiuria—Doxorubicin—testicular cancer	4.78e-05	0.000694	CcSEcCtD
Procarbazine—Haematuria—Epirubicin—testicular cancer	4.75e-05	0.00069	CcSEcCtD
Procarbazine—Dizziness—Ifosfamide—testicular cancer	4.75e-05	0.00069	CcSEcCtD
Procarbazine—Photosensitivity reaction—Doxorubicin—testicular cancer	4.72e-05	0.000686	CcSEcCtD
Procarbazine—Epistaxis—Epirubicin—testicular cancer	4.7e-05	0.000683	CcSEcCtD
Procarbazine—Feeling abnormal—Etoposide—testicular cancer	4.67e-05	0.000679	CcSEcCtD
Procarbazine—Nausea—Dactinomycin—testicular cancer	4.65e-05	0.000676	CcSEcCtD
Procarbazine—Pneumonia—Doxorubicin—testicular cancer	4.64e-05	0.000674	CcSEcCtD
Procarbazine—Gastrointestinal pain—Etoposide—testicular cancer	4.64e-05	0.000673	CcSEcCtD
Procarbazine—Drowsiness—Doxorubicin—testicular cancer	4.61e-05	0.00067	CcSEcCtD
Procarbazine—Vomiting—Ifosfamide—testicular cancer	4.57e-05	0.000663	CcSEcCtD
Procarbazine—Hypersensitivity—Cisplatin—testicular cancer	4.56e-05	0.000662	CcSEcCtD
Procarbazine—Rash—Ifosfamide—testicular cancer	4.53e-05	0.000658	CcSEcCtD
Procarbazine—Dermatitis—Ifosfamide—testicular cancer	4.52e-05	0.000657	CcSEcCtD
Procarbazine—Neuropathy peripheral—Doxorubicin—testicular cancer	4.52e-05	0.000657	CcSEcCtD
Procarbazine—Urticaria—Etoposide—testicular cancer	4.5e-05	0.000654	CcSEcCtD
Procarbazine—Haemoglobin—Epirubicin—testicular cancer	4.5e-05	0.000653	CcSEcCtD
Procarbazine—Jaundice—Doxorubicin—testicular cancer	4.5e-05	0.000653	CcSEcCtD
Procarbazine—Stomatitis—Doxorubicin—testicular cancer	4.5e-05	0.000653	CcSEcCtD
Procarbazine—Body temperature increased—Etoposide—testicular cancer	4.48e-05	0.000651	CcSEcCtD
Procarbazine—Abdominal pain—Etoposide—testicular cancer	4.48e-05	0.000651	CcSEcCtD
Procarbazine—Haemorrhage—Epirubicin—testicular cancer	4.47e-05	0.00065	CcSEcCtD
Procarbazine—Asthenia—Cisplatin—testicular cancer	4.44e-05	0.000645	CcSEcCtD
Procarbazine—Sweating—Doxorubicin—testicular cancer	4.42e-05	0.000642	CcSEcCtD
Procarbazine—Haematuria—Doxorubicin—testicular cancer	4.4e-05	0.000639	CcSEcCtD
Procarbazine—Epistaxis—Doxorubicin—testicular cancer	4.35e-05	0.000632	CcSEcCtD
Procarbazine—Chills—Methotrexate—testicular cancer	4.29e-05	0.000623	CcSEcCtD
Procarbazine—Nausea—Ifosfamide—testicular cancer	4.26e-05	0.000619	CcSEcCtD
Procarbazine—Diarrhoea—Cisplatin—testicular cancer	4.24e-05	0.000615	CcSEcCtD
Procarbazine—Alopecia—Methotrexate—testicular cancer	4.22e-05	0.000614	CcSEcCtD
Procarbazine—Hypersensitivity—Etoposide—testicular cancer	4.18e-05	0.000607	CcSEcCtD
Procarbazine—Haemoglobin—Doxorubicin—testicular cancer	4.16e-05	0.000604	CcSEcCtD
Procarbazine—Flushing—Epirubicin—testicular cancer	4.15e-05	0.000603	CcSEcCtD
Procarbazine—Haemorrhage—Doxorubicin—testicular cancer	4.14e-05	0.000601	CcSEcCtD
Procarbazine—Asthenia—Etoposide—testicular cancer	4.07e-05	0.000591	CcSEcCtD
Procarbazine—Chills—Epirubicin—testicular cancer	4.01e-05	0.000583	CcSEcCtD
Procarbazine—Pruritus—Etoposide—testicular cancer	4.01e-05	0.000583	CcSEcCtD
Procarbazine—Arrhythmia—Epirubicin—testicular cancer	4e-05	0.000581	CcSEcCtD
Procarbazine—Alopecia—Epirubicin—testicular cancer	3.95e-05	0.000574	CcSEcCtD
Procarbazine—Vomiting—Cisplatin—testicular cancer	3.94e-05	0.000572	CcSEcCtD
Procarbazine—Rash—Cisplatin—testicular cancer	3.9e-05	0.000567	CcSEcCtD
Procarbazine—Dermatitis—Cisplatin—testicular cancer	3.9e-05	0.000566	CcSEcCtD
Procarbazine—Diarrhoea—Etoposide—testicular cancer	3.88e-05	0.000564	CcSEcCtD
Procarbazine—Anaemia—Methotrexate—testicular cancer	3.85e-05	0.000559	CcSEcCtD
Procarbazine—Flushing—Doxorubicin—testicular cancer	3.84e-05	0.000558	CcSEcCtD
Procarbazine—Tension—Epirubicin—testicular cancer	3.82e-05	0.000555	CcSEcCtD
Procarbazine—Nervousness—Epirubicin—testicular cancer	3.78e-05	0.000549	CcSEcCtD
Procarbazine—Dizziness—Etoposide—testicular cancer	3.75e-05	0.000545	CcSEcCtD
Procarbazine—Leukopenia—Methotrexate—testicular cancer	3.73e-05	0.000541	CcSEcCtD
Procarbazine—Chills—Doxorubicin—testicular cancer	3.71e-05	0.00054	CcSEcCtD
Procarbazine—Arrhythmia—Doxorubicin—testicular cancer	3.7e-05	0.000537	CcSEcCtD
Procarbazine—Nausea—Cisplatin—testicular cancer	3.68e-05	0.000534	CcSEcCtD
Procarbazine—Alopecia—Doxorubicin—testicular cancer	3.66e-05	0.000531	CcSEcCtD
Procarbazine—Cough—Methotrexate—testicular cancer	3.63e-05	0.000527	CcSEcCtD
Procarbazine—Convulsion—Methotrexate—testicular cancer	3.61e-05	0.000524	CcSEcCtD
Procarbazine—Vomiting—Etoposide—testicular cancer	3.61e-05	0.000524	CcSEcCtD
Procarbazine—Anaemia—Epirubicin—testicular cancer	3.6e-05	0.000523	CcSEcCtD
Procarbazine—Rash—Etoposide—testicular cancer	3.58e-05	0.000519	CcSEcCtD
Procarbazine—Dermatitis—Etoposide—testicular cancer	3.57e-05	0.000519	CcSEcCtD
Procarbazine—Headache—Etoposide—testicular cancer	3.55e-05	0.000516	CcSEcCtD
Procarbazine—Arthralgia—Methotrexate—testicular cancer	3.54e-05	0.000515	CcSEcCtD
Procarbazine—Myalgia—Methotrexate—testicular cancer	3.54e-05	0.000515	CcSEcCtD
Procarbazine—Tension—Doxorubicin—testicular cancer	3.54e-05	0.000514	CcSEcCtD
Procarbazine—Nervousness—Doxorubicin—testicular cancer	3.5e-05	0.000508	CcSEcCtD
Procarbazine—Syncope—Epirubicin—testicular cancer	3.49e-05	0.000507	CcSEcCtD
Procarbazine—Leukopenia—Epirubicin—testicular cancer	3.49e-05	0.000506	CcSEcCtD
Procarbazine—Confusional state—Methotrexate—testicular cancer	3.42e-05	0.000497	CcSEcCtD
Procarbazine—Loss of consciousness—Epirubicin—testicular cancer	3.42e-05	0.000497	CcSEcCtD
Procarbazine—Cough—Epirubicin—testicular cancer	3.4e-05	0.000494	CcSEcCtD
Procarbazine—Convulsion—Epirubicin—testicular cancer	3.37e-05	0.00049	CcSEcCtD
Procarbazine—Infection—Methotrexate—testicular cancer	3.37e-05	0.00049	CcSEcCtD
Procarbazine—Nausea—Etoposide—testicular cancer	3.37e-05	0.000489	CcSEcCtD
Procarbazine—Hypertension—Epirubicin—testicular cancer	3.36e-05	0.000488	CcSEcCtD
Procarbazine—Anaemia—Doxorubicin—testicular cancer	3.33e-05	0.000484	CcSEcCtD
Procarbazine—Thrombocytopenia—Methotrexate—testicular cancer	3.33e-05	0.000483	CcSEcCtD
Procarbazine—Arthralgia—Epirubicin—testicular cancer	3.32e-05	0.000482	CcSEcCtD
Procarbazine—Myalgia—Epirubicin—testicular cancer	3.32e-05	0.000482	CcSEcCtD
Procarbazine—Anxiety—Epirubicin—testicular cancer	3.3e-05	0.00048	CcSEcCtD
Procarbazine—Hyperhidrosis—Methotrexate—testicular cancer	3.28e-05	0.000477	CcSEcCtD
Procarbazine—Dry mouth—Epirubicin—testicular cancer	3.24e-05	0.000471	CcSEcCtD
Procarbazine—Anorexia—Methotrexate—testicular cancer	3.24e-05	0.00047	CcSEcCtD
Procarbazine—Syncope—Doxorubicin—testicular cancer	3.23e-05	0.000469	CcSEcCtD
Procarbazine—Leukopenia—Doxorubicin—testicular cancer	3.23e-05	0.000469	CcSEcCtD
Procarbazine—Confusional state—Epirubicin—testicular cancer	3.21e-05	0.000466	CcSEcCtD
Procarbazine—Oedema—Epirubicin—testicular cancer	3.18e-05	0.000462	CcSEcCtD
Procarbazine—Hypotension—Methotrexate—testicular cancer	3.17e-05	0.000461	CcSEcCtD
Procarbazine—Loss of consciousness—Doxorubicin—testicular cancer	3.17e-05	0.00046	CcSEcCtD
Procarbazine—Infection—Epirubicin—testicular cancer	3.16e-05	0.000459	CcSEcCtD
Procarbazine—Cough—Doxorubicin—testicular cancer	3.14e-05	0.000457	CcSEcCtD
Procarbazine—Shock—Epirubicin—testicular cancer	3.13e-05	0.000454	CcSEcCtD
Procarbazine—Convulsion—Doxorubicin—testicular cancer	3.12e-05	0.000454	CcSEcCtD
Procarbazine—Thrombocytopenia—Epirubicin—testicular cancer	3.11e-05	0.000452	CcSEcCtD
Procarbazine—Hypertension—Doxorubicin—testicular cancer	3.11e-05	0.000452	CcSEcCtD
Procarbazine—Tachycardia—Epirubicin—testicular cancer	3.1e-05	0.000451	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Methotrexate—testicular cancer	3.09e-05	0.000449	CcSEcCtD
Procarbazine—Hyperhidrosis—Epirubicin—testicular cancer	3.07e-05	0.000446	CcSEcCtD
Procarbazine—Insomnia—Methotrexate—testicular cancer	3.07e-05	0.000446	CcSEcCtD
Procarbazine—Myalgia—Doxorubicin—testicular cancer	3.07e-05	0.000446	CcSEcCtD
Procarbazine—Arthralgia—Doxorubicin—testicular cancer	3.07e-05	0.000446	CcSEcCtD
Procarbazine—Anxiety—Doxorubicin—testicular cancer	3.06e-05	0.000444	CcSEcCtD
Procarbazine—Paraesthesia—Methotrexate—testicular cancer	3.05e-05	0.000443	CcSEcCtD
Procarbazine—Anorexia—Epirubicin—testicular cancer	3.03e-05	0.00044	CcSEcCtD
Procarbazine—Somnolence—Methotrexate—testicular cancer	3.02e-05	0.000439	CcSEcCtD
Procarbazine—Dry mouth—Doxorubicin—testicular cancer	3e-05	0.000436	CcSEcCtD
Procarbazine—Hypotension—Epirubicin—testicular cancer	2.97e-05	0.000431	CcSEcCtD
Procarbazine—Confusional state—Doxorubicin—testicular cancer	2.97e-05	0.000431	CcSEcCtD
Procarbazine—Decreased appetite—Methotrexate—testicular cancer	2.95e-05	0.000429	CcSEcCtD
Procarbazine—Oedema—Doxorubicin—testicular cancer	2.94e-05	0.000427	CcSEcCtD
Procarbazine—Fatigue—Methotrexate—testicular cancer	2.93e-05	0.000425	CcSEcCtD
Procarbazine—Infection—Doxorubicin—testicular cancer	2.92e-05	0.000424	CcSEcCtD
Procarbazine—Pain—Methotrexate—testicular cancer	2.9e-05	0.000422	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Epirubicin—testicular cancer	2.9e-05	0.000421	CcSEcCtD
Procarbazine—Shock—Doxorubicin—testicular cancer	2.89e-05	0.00042	CcSEcCtD
Procarbazine—Thrombocytopenia—Doxorubicin—testicular cancer	2.88e-05	0.000418	CcSEcCtD
Procarbazine—Insomnia—Epirubicin—testicular cancer	2.88e-05	0.000418	CcSEcCtD
Procarbazine—Tachycardia—Doxorubicin—testicular cancer	2.87e-05	0.000417	CcSEcCtD
Procarbazine—Paraesthesia—Epirubicin—testicular cancer	2.85e-05	0.000415	CcSEcCtD
Procarbazine—Hyperhidrosis—Doxorubicin—testicular cancer	2.84e-05	0.000413	CcSEcCtD
Procarbazine—Somnolence—Epirubicin—testicular cancer	2.83e-05	0.00041	CcSEcCtD
Procarbazine—Anorexia—Doxorubicin—testicular cancer	2.8e-05	0.000407	CcSEcCtD
Procarbazine—Feeling abnormal—Methotrexate—testicular cancer	2.8e-05	0.000407	CcSEcCtD
Procarbazine—Gastrointestinal pain—Methotrexate—testicular cancer	2.78e-05	0.000403	CcSEcCtD
Procarbazine—Decreased appetite—Epirubicin—testicular cancer	2.76e-05	0.000401	CcSEcCtD
Procarbazine—Hypotension—Doxorubicin—testicular cancer	2.75e-05	0.000399	CcSEcCtD
Procarbazine—Fatigue—Epirubicin—testicular cancer	2.74e-05	0.000398	CcSEcCtD
Procarbazine—Pain—Epirubicin—testicular cancer	2.72e-05	0.000395	CcSEcCtD
Procarbazine—Constipation—Epirubicin—testicular cancer	2.72e-05	0.000395	CcSEcCtD
Procarbazine—Urticaria—Methotrexate—testicular cancer	2.7e-05	0.000392	CcSEcCtD
Procarbazine—Abdominal pain—Methotrexate—testicular cancer	2.69e-05	0.00039	CcSEcCtD
Procarbazine—Body temperature increased—Methotrexate—testicular cancer	2.69e-05	0.00039	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	2.68e-05	0.000389	CcSEcCtD
Procarbazine—Insomnia—Doxorubicin—testicular cancer	2.66e-05	0.000386	CcSEcCtD
Procarbazine—Paraesthesia—Doxorubicin—testicular cancer	2.64e-05	0.000384	CcSEcCtD
Procarbazine—Feeling abnormal—Epirubicin—testicular cancer	2.62e-05	0.00038	CcSEcCtD
Procarbazine—Somnolence—Doxorubicin—testicular cancer	2.61e-05	0.00038	CcSEcCtD
Procarbazine—Gastrointestinal pain—Epirubicin—testicular cancer	2.6e-05	0.000378	CcSEcCtD
Procarbazine—Decreased appetite—Doxorubicin—testicular cancer	2.56e-05	0.000371	CcSEcCtD
Procarbazine—Fatigue—Doxorubicin—testicular cancer	2.54e-05	0.000368	CcSEcCtD
Procarbazine—Urticaria—Epirubicin—testicular cancer	2.53e-05	0.000367	CcSEcCtD
Procarbazine—Pain—Doxorubicin—testicular cancer	2.52e-05	0.000365	CcSEcCtD
Procarbazine—Constipation—Doxorubicin—testicular cancer	2.52e-05	0.000365	CcSEcCtD
Procarbazine—Abdominal pain—Epirubicin—testicular cancer	2.51e-05	0.000365	CcSEcCtD
Procarbazine—Body temperature increased—Epirubicin—testicular cancer	2.51e-05	0.000365	CcSEcCtD
Procarbazine—Hypersensitivity—Methotrexate—testicular cancer	2.5e-05	0.000363	CcSEcCtD
Procarbazine—Asthenia—Methotrexate—testicular cancer	2.44e-05	0.000354	CcSEcCtD
Procarbazine—Feeling abnormal—Doxorubicin—testicular cancer	2.42e-05	0.000352	CcSEcCtD
Procarbazine—Gastrointestinal pain—Doxorubicin—testicular cancer	2.41e-05	0.000349	CcSEcCtD
Procarbazine—Pruritus—Methotrexate—testicular cancer	2.4e-05	0.000349	CcSEcCtD
Procarbazine—Hypersensitivity—Epirubicin—testicular cancer	2.34e-05	0.00034	CcSEcCtD
Procarbazine—Urticaria—Doxorubicin—testicular cancer	2.34e-05	0.000339	CcSEcCtD
Procarbazine—Abdominal pain—Doxorubicin—testicular cancer	2.33e-05	0.000338	CcSEcCtD
Procarbazine—Body temperature increased—Doxorubicin—testicular cancer	2.33e-05	0.000338	CcSEcCtD
Procarbazine—Diarrhoea—Methotrexate—testicular cancer	2.32e-05	0.000338	CcSEcCtD
Procarbazine—Asthenia—Epirubicin—testicular cancer	2.28e-05	0.000331	CcSEcCtD
Procarbazine—Pruritus—Epirubicin—testicular cancer	2.25e-05	0.000327	CcSEcCtD
Procarbazine—Dizziness—Methotrexate—testicular cancer	2.25e-05	0.000326	CcSEcCtD
Procarbazine—Diarrhoea—Epirubicin—testicular cancer	2.17e-05	0.000316	CcSEcCtD
Procarbazine—Hypersensitivity—Doxorubicin—testicular cancer	2.17e-05	0.000315	CcSEcCtD
Procarbazine—Vomiting—Methotrexate—testicular cancer	2.16e-05	0.000314	CcSEcCtD
Procarbazine—Rash—Methotrexate—testicular cancer	2.14e-05	0.000311	CcSEcCtD
Procarbazine—Dermatitis—Methotrexate—testicular cancer	2.14e-05	0.000311	CcSEcCtD
Procarbazine—Headache—Methotrexate—testicular cancer	2.13e-05	0.000309	CcSEcCtD
Procarbazine—Asthenia—Doxorubicin—testicular cancer	2.11e-05	0.000306	CcSEcCtD
Procarbazine—Dizziness—Epirubicin—testicular cancer	2.1e-05	0.000305	CcSEcCtD
Procarbazine—Pruritus—Doxorubicin—testicular cancer	2.08e-05	0.000302	CcSEcCtD
Procarbazine—Vomiting—Epirubicin—testicular cancer	2.02e-05	0.000294	CcSEcCtD
Procarbazine—Nausea—Methotrexate—testicular cancer	2.02e-05	0.000293	CcSEcCtD
Procarbazine—Diarrhoea—Doxorubicin—testicular cancer	2.01e-05	0.000292	CcSEcCtD
Procarbazine—Rash—Epirubicin—testicular cancer	2e-05	0.000291	CcSEcCtD
Procarbazine—Dermatitis—Epirubicin—testicular cancer	2e-05	0.000291	CcSEcCtD
Procarbazine—Headache—Epirubicin—testicular cancer	1.99e-05	0.000289	CcSEcCtD
Procarbazine—Dizziness—Doxorubicin—testicular cancer	1.94e-05	0.000282	CcSEcCtD
Procarbazine—Nausea—Epirubicin—testicular cancer	1.89e-05	0.000274	CcSEcCtD
Procarbazine—Vomiting—Doxorubicin—testicular cancer	1.87e-05	0.000272	CcSEcCtD
Procarbazine—Rash—Doxorubicin—testicular cancer	1.85e-05	0.000269	CcSEcCtD
Procarbazine—Dermatitis—Doxorubicin—testicular cancer	1.85e-05	0.000269	CcSEcCtD
Procarbazine—Headache—Doxorubicin—testicular cancer	1.84e-05	0.000268	CcSEcCtD
Procarbazine—Nausea—Doxorubicin—testicular cancer	1.75e-05	0.000254	CcSEcCtD
